SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulfs better-than-expected quarterly results and Googles credit support for financing tied to its Anthropic data-center lease are driving attention. Bulls see the financing and AI infrastructure demand as supportive, while skeptics point to the stocks weak reaction, heavy debt, construction execution risks, and uncertainty around data-center regulation.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings sharp selloff follows a Q3 earnings miss and a steep cut to its full-year outlook, with heavy investment in its Predictions business cited as a major drag on expected profitability. Traders are broadly criticizing management, spending and competitive pressures from prediction-market rivals, while some argue the core sportsbook remains healthy and are buying the drop.

Firefly Aerospace, Inc. engages in the design and manufacture of space launch vehicles. The company was founded by Thomas E. Markusic, Mark Watt, and Max Polyakov in January 2017 and is headquartered in Leander, TX.

Firefly Aerospace Inc.

Fireflys multi-year agreement to supply rocket engines, licensed technology, and engineering support for AST SpaceMobiles heavy-lift rocket is drawing attention. Traders largely view the deal as a major commercial validation and potential boost to Fireflys backlog and funding, while some question the execution demands and what the arrangement means for ASTs launch plans.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklos rebound is drawing attention after its Q3 business update and a manufacturing agreement reserving capacity for future Aurora reactor components. Bulls see the agreement as progress, while skeptics point to minimal current revenue, long commercialization timelines, and dilution and valuation concerns.

AST SpaceMobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an intellectual property and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobiles Firefly engine agreement and plan to develop its own heavy-lift rocket have sparked debate over whether greater control of satellite launches can ease a key bottleneck. Traders are split between viewing the move as a long-term strategic step and worrying about its cost, execution risk, and potential dilution.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS is drawing attention as traders await topline survival results from the Phase 3 REGAL trial of its AML drug candidate GPS; the community says the trial reached its 80th event and is in final analysis, with results expected this quarter. Optimism about the readout and separate SLS009 data is running against concern over the sharp share-price decline, with traders debating whether it reflects broad-market pressure or doubts about the company and its prospects.

Western Digital Corp. engages in the development, manufacture, marketing, and sale of data storage devices and solutions. It operates through the Hard Disk Drives (HDD) segment. The company was founded by Alvin B. Phillips in 1970 and is headquartered in San Jose, CA.

Western Digital Corp.

Concerns that political opposition could slow U.S. data-center construction have fueled selling in AI-related storage and semiconductor stocks, including WDC. Traders debate whether that risk threatens storage demand: bears see a possible buildout slowdown, while bulls point to strong company results and ongoing demand for data storage.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Modernas stronger-than-expected quarterly results and raised revenue outlook, supported by vaccine sales, are driving attention. Traders are split over whether the improved results and pipeline prospects justify the valuation, with skeptics pointing to cash burn and a sharp sell-the-news reversal after the initial rally.

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. The company's products include Tavalisse, Fostamatinib and R835. Rigel Pharmaceuticals was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.

Rigel Pharmaceuticals

Rigels quarterly results have sparked a sharp selloff, with traders focused on an earnings shortfall and concerns about profitability and legacy-product trends despite VEPPANUs promising early launch. Bulls point to VEPPANUs growth potential and upcoming R289 data, while bears question how quickly the new drug can offset pressure on older products.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is volatile amid a sharp semiconductor selloff and rebound, as traders debate whether election-related calls for tighter data-center rules could slow AI infrastructure spending. Bulls argue demand for its chips remains strong and projects can shift elsewhere, while bears see risks to AI capex and valuations.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Prestige Consumer Healthcare (PBH) Beats Q2 Earnings and Revenue Estimates

Prestige Consumer Healthcare (PBH) delivered earnings and revenue surprises of +6.60% and +2.31%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

Noteworthy Monday Option Activity: OSUR, TMDX, DSP

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in OraSure Technologies Inc. (Symbol: OSUR), where a total volume of 7,520 contracts has been traded thus far today, a contract volume which is representative of ap...

Peapod Lane Capital LLC Has $2.47 Million Position in OraSure Technologies, Inc. $OSUR

Peapod Lane Capital LLC raised its stake in OraSure Technologies, Inc. (NASDAQ:OSUR - Free Report) by 51.1% during the 4th quarter, according to the company in its most recent disclosure with the...

OraSure Technologies (NASDAQ:OSUR) Stock Passes Above Two Hundred Day Moving Average - Time to Sell?

OraSure Technologies (NASDAQ:OSUR) Stock Price Passes Above 200-Day Moving Average - What's Next...

OraSure Technologies Sees Unusually High Options Volume (NASDAQ:OSUR)

OraSure Technologies, Inc. (NASDAQ:OSUR - Get Free Report) was the target of some unusual options trading on Monday. Traders acquired 7,008 call options on the stock. This is an increase of 2,394% compared to the average volume of 281 call options...

OraSure Technologies (NASDAQ:OSUR) Stock Crosses Above Two Hundred Day Moving Average - Here's Why

OraSure Technologies (NASDAQ:OSUR) Stock Price Crosses Above 200-Day Moving Average - Here's What Happened...

OraSure Technologies (NASDAQ:OSUR) Stock Crosses Above 200-Day Moving Average - Here's What Happened

OraSure Technologies (NASDAQ:OSUR) Shares Pass Above 200 Day Moving Average - Time to Sell...

Manner Carrie Eglinton Buys 32,300 Shares of OraSure Technologies (NASDAQ:OSUR) Stock

OraSure Technologies, Inc. (NASDAQ:OSUR - Get Free Report) CEO Manner Carrie Eglinton purchased 32,300 shares of the stock in a transaction on Friday, March 20th. The shares were purchased at an...

Manner Carrie Eglinton Acquires 32,300 Shares of OraSure Technologies (NASDAQ:OSUR) Stock

OraSure Technologies, Inc. (NASDAQ:OSUR - Get Free Report) CEO Manner Carrie Eglinton bought 32,300 shares of the firm's stock in a transaction that occurred on Friday, March 20th. The stock was bought at an average cost of $2.93 per share, for a total transaction of $94,639.00. Following the...

Insider Buying: OraSure Technologies (NASDAQ:OSUR) CFO Purchases 32,300 Shares of Stock

OraSure Technologies, Inc. (NASDAQ:OSUR - Get Free Report) CFO Kenneth Mcgrath bought 32,300 shares of the business's stock in a transaction on Friday, March 20th. The stock was bought at an average price of $2.93 per share, for a total transaction of $94,639.00. Following the transaction, the...

OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic tests and molecular collection devices designed to detect or diagnose critical medical conditions. It operates through the OSUR and DNAG segments. The OSUR segment offers oral fluid diagnostic products and specimen collection devices. The DNAG segment produces specimen collection kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, pharmacogenomics, personalized medicine, microbiome, and animal genetics markets. The company was founded by Michael J. Gausling in 2000 in and is headquartered in Bethlehem, PA.

Orasure Technologies Inc.

Hedge Fund Reportedly Prepares To Launch Board Fight At OraSure Technologies: Retail Investors Believe It’s Good News

Equity

Bearish Sentiment

Altai Capital Management is reportedly preparing to launch a board fight at medical device company OraSure Technologies (OSUR).The hedge fund is one of the biggest owners of OraSure and built up its stake from 3% at the end of June to 5% in recent weeks, Reuters <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.reuters.com/legal/transactional/altai-capital-lays-groundwork-board-fight-orasure-technologies-sources-say-2025-09-09/">reported</a>, citing two people familiar with the matter.The larger stake allows Altai to press its case for board representation more forcefully, the people told Reuters. Two OraSure directors will stand for reelection at next year's annual meeting, and Altai is likely to nominate two candidates, including its founder, Rishi Bajaj, at some point, the report stated. Bajaj last year suggested that an investor with experience in capital allocation should join the OraSure board, the sources told Reuters.Shares of the company traded 2% higher at the time of writing. On Stocktwits, retail sentiment regarding <a href="https://stocktwits.com/symbol/OSUR">OSUR stock</a> remained in ‘bearish’ territory over the past 24 hours, while message volume remained at ‘normal’ levels.<figure class="image"><img style="aspect-ratio:573/62;" src="https://news.stocktwits-cdn.com/Screenshot_2025_09_09_at_12_44_48_PM_png_7a065a0f80.webp" alt="OSUR's Sentiment Meter and Message Volume as of 12:45 p.m. ET on Sept. 9, 2025 | Source: Stocktwits" width="573" height="62"><figcaption>OSUR's Sentiment Meter and Message Volume as of 12:45 p.m. ET on Sept. 9, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user believes it’s ‘good news’.<stembedurl>https://stocktwits.com/Gantz7/message/627948069</stembedurl>However, another user cheered for the Altai founder.<stembedurl>https://stocktwits.com/AnonMav/message/627979684</stembedurl>Last month, Reuters reported that OraSure Technologies (OSUR) received a letter from healthcare entrepreneur Ron Zwanziger stating that he may pursue a more "adversarial path" if the board continues to resist his offer to buy the company.Zwanziger made an unsolicited all-cash offer to buy OraSure for between $3.50 and $4.00 a share in June but was rebuffed. The entrepreneur stated in his letter that other investors have grown concerned and reached out to him."If the board is not willing to entertain a collaborative discourse, we will be left with no choice but to consider all alternatives available," the letter <a href="https://stocktwits.com/news-articles/markets/equity/orasure-receives-warning-from-ron-zwanziger/chssxJ9RdS9">said</a>, without detailing the alternative options. "We would prefer to work together with you in a collaborative fashion to realize the full value potential for all shareholders, rather than pursuing a more adversarial path," the letter stated, as per the report. However, Altai and Zwanziger are not working together, Reuters said on Tuesday.For the three months through the end of June, OraSure’s total net revenues fell 43% year-on-year to $31.24 million, while diluted and adjusted loss per share stood at $0.19 compared to a profit of $0.08 in the corresponding quarter of 2024.OSUR stock is down 8% this year and approximately 21% over the past 12 months.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/gary-black-expects-tesla-q3-deliveries-to-exceed-wall-street-estimates-but-sees-full-year-numbers-slip/chwK7ojRdtl">Gary Black Expects Tesla Q3 Deliveries To Exceed Wall Street Estimates But Sees Full-Year Numbers Slip: Retail’s Divided On Stock Performance</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Global stock market chart and trading board - stock photo

Altai Capital Management is one of the largest owners of OraSure and has increased its stake from 3% at the end of June to 5% in recent weeks, in an effort to press for board representation, Reuters reported.  

iShares Russell 2000 BuyWrite ETF

Vanguard Group, Inc. - Vanguard U.S. Multifactor ETF

Fundamental investor

Technical trader

A mix of both

Fundamental analysis looks at earnings, valuation, and business quality, while technical analysis focuses on chart patterns, price action, and indicators, and many investors blend the two. How do you decide what to buy: fundamentals or technicals? Vote and explain your reasoning in the comments.

Feed

News

Sentiment

Earnings

Fundamentals

Info

OSUR News